133 related articles for article (PubMed ID: 2462815)
21. the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome.
Cook SD; Dowling PC
Ann Neurol; 1981; 9 Suppl():70-9. PubMed ID: 6452856
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis.
Vriesendorp FJ; Mayer RF; Koski CL
Arch Neurol; 1991 Aug; 48(8):858-61. PubMed ID: 1898263
[TBL] [Abstract][Full Text] [Related]
23. P2-reactive T cells in inflammatory demyelination of the peripheral nerve.
Rostami AM
J Infect Dis; 1997 Dec; 176 Suppl 2():S160-3. PubMed ID: 9396703
[TBL] [Abstract][Full Text] [Related]
24. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
25. Relationship between autoantibody specificities and peripheral nervous system involvements.
Jauberteau-Marchan MO
Clin Rev Allergy Immunol; 2000 Aug; 19(1):41-9. PubMed ID: 11064825
[No Abstract] [Full Text] [Related]
26. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
Vedeler CA; Nyland H
Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue.
Nyland H; Vedeler CA; Matre R; Halvorsen K; Fagius J; Osterman PO; Janzen RW; Skre H
Int J Artif Organs; 1984 May; 7(3):133-6. PubMed ID: 6735503
[TBL] [Abstract][Full Text] [Related]
28. [Antiganglioside antibodies in peripheral neuropathies].
Pardo J
Neurologia; 2001; 16(7):289-92. PubMed ID: 11485720
[No Abstract] [Full Text] [Related]
29. T cell responses to myelin proteins in Guillain-Barré syndrome.
Khalili-Shirazi A; Hughes RA; Brostoff SW; Linington C; Gregson N
J Neurol Sci; 1992 Sep; 111(2):200-3. PubMed ID: 1279128
[TBL] [Abstract][Full Text] [Related]
30. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.
Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A
J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to phospholipids and brain extract in patients with the Guillain-Barre syndrome: cross-reactive or pathogenic?
Gilburd B; Stein M; Tomer Y; Tanne D; Abramski O; Chapman Y; Ahiron A; Blank M; Shoenfeld Y
Autoimmunity; 1993; 16(1):23-7. PubMed ID: 8136463
[TBL] [Abstract][Full Text] [Related]
33. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
34. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
Ho TW; Mishu B; Li CY; Gao CY; Cornblath DR; Griffin JW; Asbury AK; Blaser MJ; McKhann GM
Brain; 1995 Jun; 118 ( Pt 3)():597-605. PubMed ID: 7600081
[TBL] [Abstract][Full Text] [Related]
35. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
[TBL] [Abstract][Full Text] [Related]
36. [Inflammatory demyelinating diseases if the peripheral nervous system: immunological concepts and experimental models].
Vass K; Lassmann H
Wien Klin Wochenschr Suppl; 1991; 190():13-6. PubMed ID: 1771901
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique.
Vedeler CA; Nyland H; Matre R
J Neuroimmunol; 1982 Jun; 2(3-4):209-14. PubMed ID: 7085862
[TBL] [Abstract][Full Text] [Related]
38. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients.
Brechenmacher C; Vital C; Deminiere C; Laurentjoye L; Castaing Y; Gbikpi-Benissan G; Cardinaud JP; Favarel-Garrigues JP
Clin Neuropathol; 1987; 6(1):19-24. PubMed ID: 3552352
[TBL] [Abstract][Full Text] [Related]
39. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
[TBL] [Abstract][Full Text] [Related]
40. Extra- and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index.
Ryberg B
Neurology; 1984 Oct; 34(10):1378-81. PubMed ID: 6541314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
